This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Song, F. Articles by Woolacott, N. Search for Related Content PubMed PubMed Citation Articles by Song, F. Articles by Woolacott, N. Social Bookmarking                         What's this?

Cost-Effectiveness of Pharmacological Interventions for Smoking Cessation: a Literature Review and a Decision Analytic Analysis

Department of Public Health and Epidemiology, University of Birmingham, Edgbaston, Birmingham, UK f.song{at}bham.ac.uk

James Raftery, PhD

Health Services Management Centre, University of Birmingham, Birmingham, UK

Paul Aveyard, PhD

Department of Public Health and Epidemiology, University of Birmingham, Edgbaston, Birmingham, UK

Chris Hyde, MD

Department of Public Health and Epidemiology, University of Birmingham, Edgbaston, Birmingham, UK

Pelham Barton, PhD

Health Services Management Centre, University of Birmingham, Birmingham, UK

Nerys Woolacott, PhD

National Health Services Centre for Reviews and Dissemination, University of York, York, UK

To evaluate the relative cost-effectiveness of nicotine replacement therapy (NRT) and bupropion SR for smoking cessation, the authors reviewed published studies and developed a decision analytic model from the UK National Health Services perspective. Irrespective of the methods or assumptions involved, the results of published studies consistently indicated that NRT for smoking cessation is cost-effective. No published studies have evaluated the relative cost-effectiveness of bupropion SR for smoking cessation. The results of the decision analyses indicated that, as compared with advice or counseling alone, the incremental cost per life-years saved is about $1,441~$3,455 for NRT, $920~$2,150 for bupropion SR, and $1,282~$2,836 for NRT plus bupropion SR. The cost-effectiveness of adding NRT and bupropion SR to advice or counseling for smoking cessation is better than many other accepted health care interventions.

Key Words: decision analysis • cost-effectiveness • smoking cessation • nicotine replacement therapy (NRT) • bupropion SR

Medical Decision Making, Vol. 22, No. 5 suppl, S26-S37 (2002)
DOI: 10.1177/027298902237708


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				H. J. Salize, S. Merkel, I. Reinhard, D. Twardella, K. Mann, and H. Brenner Cost-effective Primary Care-Based Strategies to Improve Smoking Cessation: More Value for Money Arch Intern Med, February 9, 2009; 169(3): 230 - 235. [Abstract] [Full Text] [PDF]

				G. Hejblum, K. Atsou, B. Dautzenberg, and C. Chouaid Cost-Benefit Analysis of a Simulated Institution-Based Preoperative Smoking Cessation Intervention in Patients Undergoing Total Hip and Knee Arthroplasties in France Chest, February 1, 2009; 135(2): 477 - 483. [Abstract] [Full Text] [PDF]

				L. Carrozzi, F. Pistelli, and G. Viegi Review: Pharmacotherapy for smoking cessation Therapeutic Advances in Respiratory Disease, October 1, 2008; 2(5): 301 - 317. [Abstract] [PDF]

				D. K. Owens Analytic Tools for Public Health Decision Making Med Decis Making, October 1, 2002; 22(5_suppl): S3 - S10. [PDF]